Literature DB >> 12796986

Indomethacin and amniocentesis-induced changes in fetal flow velocity waveforms.

Z Weinraub1, O M Avrech, A Golan, P Zabow, R Ron-El, I Bukovsky, E Caspi.   

Abstract

The effect of genetic amniocentesis on flow velocity waveforms in the fetal aorta and the umbilical artery, and fetal heart rate and their correlation with uterine contractions was examined in 75 pregnant women who underwent this procedure. Forty-three were untreated and 32 were pretreated with indomethacin. Median maternal age was 36 years and median gestational age was 18 weeks. The resistance index of waveforms from the fetal aorta was stable at 0.8 throughout the approximately 20-h study period in both groups, but the systolic/diastolic ratio in the umbilical artery increased significantly after amniocentesis in the untreated group, and remained stable in the treated group. Fetal heart rate remained at about 150 beats/min throughout all measurements in both groups. These findings indicate that genetic amniocentesis causes an increase in downstream resistance in the umbilical artery which, however, remains within normal limits. This mild fetoplacental response to amniocentesis can be suppressed by the administration of a potent prostaglandin inhibitor like indomethacin. Copyright 1992 International Society of Ultrasound in Obstetrics and Gynecology

Entities:  

Year:  1992        PMID: 12796986     DOI: 10.1046/j.1469-0705.1992.02020104.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  2 in total

1.  Does bleeding affect fetal Doppler parameters during genetic amniocentesis?

Authors:  Cantekin Iskender; Ebru Tarım; Tayfun Cok; Hakan Kalaycı; Ayşe Parlakgümüş; Cem Yalçınkaya
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-06-01

2.  Ductus Venosus Doppler Flow Velocity after Transplacental and Non-transplacental Amniocentesis during Midtrimester.

Authors:  Burcu Artunc Ulkumen; Halil Gursoy Pala; Yesim Bulbul Baytur; Faik Mumtaz Koyuncu
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.